Background: Murine xenotropic leukemia virus-related virus (XMulV) is used as a model virus in the evaluation of viral inactivation in Chinese hamster ovary (CHO) cell-derived pharmaceutical proteins. Mus dunni cells and mink lung cells are used to produce XMulV particles. In consideration of the characteristics of XMulV, we tried to propagate the viruses on CHO cells, a nonmurine cell line. Methods: The viruses were harvested from CHO cells from Day 2 to Day 7 postinfection, and reverse transcription-quantitative polymerase chain reaction was performed to quantify the viruses on different days. A cell-based infectivity assay was used to evaluate the XMulV titers. Results: The content of the XMulV virions began to increase on Day 5 and grew exponentially from Day 6 to Day 7 postinfection. The growth curve was a typical single-step growth curve. Titers of the viral stock harvested on Day 7 were assayed on PG-4 cells, and the titers were 8.78 AE 0.25 log 10 PFU/mL. Conclusion: Based on these data, we conclude that CHO cells could be a host cell line for XMulV particles. XMulV produced on Day 7 in CHO cells could be used at a laboratory scale for the evaluation of XMulV clearance in pharmaceutical proteins derived from CHO cells.
Introduction
Xenotropic murine leukemia virus-related virus (XMulV) is a kind of gamma retrovirus. Although derived from endogenous sequences of inbred mice, the virus does not exogenously infect mouse cells, except certain cells of wild mouse origin such as Mus dunni cells. Thus, the virus is called "xenotropic." XMulV has a dimer genomic RNA, which is surrounded by a capsid. It is typically used as a model virus in the evaluation of viral inactivation in CHO-derived biological products. Host organisms of XMulV include M. dunni cells, mink lung cells, and other nonmurine cells. The virus produces foci of round cells on mink lung cells MiCl1 and plaque-like foci on feline cell line, PG-4. Both the MiCl1 cells and the PG-4 cells are sarcoma virus-positive and leukemia virus-negative cell lines, which are abbreviated as SþLÀ.
The Chinese hamster ovary (CHO) cell line is one of the nonmurine cell lines and is the cell line most widely used for the production of pharmaceutical proteins. Early studies have demonstrated that there are endogenous gamma retroviruses in CHO cells. 1 This revealed the fact that gamma retrovirus could grow in CHO cells. In addition, there is no cytopathic effect on CHO cells. Thus, it is beneficial for the virus to grow in CHO cells.
In this study, we investigated the development of XMulV in CHO cells by SYBR Green fluorescence quantitative polymerase chain reaction (qPCR) and drew a growth curve of the virus cocultured with CHO cells from Day 2 to Day 7. In order to examine the activity of XMulV harvested from CHO cells, a cell-based infectivity assay, the PG-4 SþLÀ assay, was performed.
Methods

Cell culture and passage
The CHO cell line was provided as a gift by Dr Minggang Bi, and the growth media for the cells were Dulbecco's modified Eagle's medium (DMEM)/F12 (1:1, HyClone, UT, USA) with 10% fetal bovine serum (FBS). The cells were cultured at 37 C in 5% CO 2 environment and passaged two or three times per week.
PG-4, a feline brain cell line (SþLÀ), was purchased from the American Type Culture Collection (ATCC; Catalog No. CRL-2032). The cells are adherent astrocytes, and were grown in modified McCoy's 5A medium (Invitrogen, Carlsbad, CA, USA) with 10% FBS and cultured at 37 C in 5% CO 2 environment, and were passaged with 0.25% trypsin solution two or three times weekly.
Virus
The murine xenotropic leukemia virus-related virus, strain pNFS Th-1, was purchased from the ATCC (Catalog No.VR-1447).
Virus propagation on CHO cells
CHO cells were seeded into a tissue culture flask (25 cm 2 ) in triplicate at a density of 5 Â 10 5 per mL. After cultivating for 24 hours, the cells were inoculated with 1 mL of 10-fold diluted XMulV stock (from the ATCC) containing 8.0 mg/mL of polybrene (Sigma-Aldrich, St. Louis, MO, USA). After 1.5 hours of adsorption, another 9 mL of DMEM/F12 (1:1) with 5% FBS was added. The cocultivation lasts for 7 days. On Day 7, the coculture samples were harvested and resuspended in 1 mL of noncomplete DMEM/F12 medium (1:1). The suspension was frozen-thawed repetitively, and then the XMulV supernatant was obtained by ultracentrifugation. The suspension served as a viral stock and was used in the following experiments.
Cultivation of XMulV in CHO cells from Day 2 to Day 7
CHO cells were seeded into six-well plates in triplicate at a density of 5 Â 10 4 per well. After 24 hours of cultivation, the cells were inoculated with 0.5 mL of 10-fold diluted XMulV stock (prepared as described in the section "Virus propagation on CHO cells"), which contained 8.0 mg/mL of polybrene. After 1.5 hours of adsorption, 3.5 mL of DMEM/F12 (1:1) medium with 5% FBS was added. The coculture test samples were harvested on Day 2, Day 3, Day 4, Day 5, Day 6, and Day 7, respectively.
Total RNA extraction
Total RNA was extracted from the samples prepared as described in the section "Cultivation of XMulV in CHO cells from Day 2 to Day 7" using Trizol (Invitrogen), chloroform, isopropanol, and 75% alcohol. Then the RNA was dissolved in 0.1% DEPC (diethyl pyrocarbonate)-processed water.
Reverse transcription-qPCR
Reverse transcription reaction
Total RNA was transcribed into cDNA immediately using the First Strand cDNA Synthesis Kit (Toyobo, Tokyo, Japan). Briefly, total RNA in DEPC-processed water was added to 5Â reverse transcription (RT) reaction mix, resulting in a final concentration of 25 mM MgCl 2 10 mM dNTP mixture 10 mM reverse primer and 0.5 U/mL RNase inhibitor. Reformative MMLV had a final concentration of 0.5 U/mL. There was no template in negative control. After a 5-minute incubation at 65 C of RNA denaturation, the RT buffers were added, and the tubes were cooled to 42 C for RT. Each sample was set up in triplicate.
PCR reaction
In PCR reaction, an equal volume cDNA was added to 2Â PCR mixture. To amplify the XMulV gene, part of the XMuLV genome was sequenced. Two primers were used for sequencing: 0 -CCC TGA AGTACC CCATTG AAC ACG-3 0 (forward) and 5 0 -GAT AGA ACG GCA GAA GAA AGA CAA-3 0 (reverse). The size of the b-actin product was 251 bp. Amplicons of the two genes were obtained by SYBR Green real-time PCR Master Mix (Toyobo) using the iQ5.0 real-time PCR detection system (BioRad Laboratories, Berkeley, CA, USA). For the gag gene, the amplification began with a 10-minute incubation at 95 C to predegeneration, followed by 40 cycles of denaturation at 95 C for 15 seconds, annealing at 55. 8 C for 15 seconds, and extension at 72 C for 45 seconds, then a cycle of terminal extension at 72 C for 6 minutes. For the b-actin gene, the procedures of amplification were the same as that of the gag gene, except for the annealing temperature. For the b-actin gene, it was 55 C. Each sample was detected in three instances at different times.
PG-4 cell SþLÀ assay
PG-4 cells were seeded into the six-well plate at a density of 3 Â 10 5 per well in 4.0 mL of the growth medium. The plates were incubated at 37 C in 5% CO 2 environment for 24 hours. Then the media were replaced with 10-fold diluted serial solutions from 10 5 to 10 7 folds of the XMulV stock (prepared as described in the section "Virus propagation on CHO cells"), which contained 8.0 mg/mL polybrene. Then, 0.5 mL of each diluted solution was inoculated into each of the three replicate wells. A negative control group was also prepared. After 1.5 hours of adsorption, another 3.5 mL of the maintenance medium was added. On Day 1 and Day 4 of inoculation, the medium was replaced with fresh medium. On 
Statistical analysis
Relative quantities of XMulV were calculated by the 2 ÀDDCt method using the reference gene as a calibrator, and the data were compared using Student's t test. Significance was set at p < 0.05. 
Results
Gag gene detected in CHO cells from Day 2 to Day 7
The PCR amplification curve and the melting curve of the two genes are shown in Fig. 1 . The RNA content of the gag gene is presented in Table 1 . The relative content of the gag gene began to increase on Day 5, and it was 13 times higher on Day 7 than on Day 2. The gene content on Day 7 was significantly higher than that on Day 2 ( p < 0.01). The growth curve of XMulV cultivated in CHO cells is shown in Fig. 2 . The development of XMulV in CHO cells was in line with an exponential trend, and the R 2 of the exponential equation was 0.9125.
Titer of XMulV observed on PG-4 cells
Plaques were read using a microscope at Â40 magnification (Model DP-72, Olympus, Tokyo, Japan), and the plaques formed in different diluted solutions are shown in Fig. 3 .
Plaques in the 10 5 -fold and the 10 6 -fold dilution serials were too numerous to count. Titer was calculated according to the number of plaques in the 10 7 -fold diluted viral solution, and the viral titer was 8.78 AE 0.25 log 10 PFU/mL.
Discussion
XMulV is a gamma retrovirus. It was previously believed to be a noninfectious retrovirus, but currently it has proven to be an infectious human virus 2e4 : the virus was detected in the tissue of patients with chronic fatigue syndrome. However, its viral classification and presence in chronic fatigue patients remain controversial. 5 XMulV is used as a model virus in the evaluation of retroviral clearance in CHO-derived pharmaceutical proteins.
At present, M. dunni cells and mink lung cells are used to propagate the XMulV particles, and other host cells of this viral particle have not been studied. For the "xenotropic" character of the virus, we considered using CHO cells to propagate the virus. The CHO cell line, which is a nonmurine cell line, is often used as a vehicle in the production of pharmaceutical proteins. At present, there are many pharmaceutical proteins in industrial production using CHO cell culture processes. 6, 7 In addition to a variety of favorable factors that aredfor exogenous gene expressiondmediated by retroviral transfection, many protein drugs are expressed through the retrovirus-mediated transfection in CHO cells. 8 The process of XMulV entering into CHO cells has been studied in Côté et al's research. 9 In their study, entry of XMulV particles into CHO cells and titers of XMRV Env pseudovirions in CHO cells were investigated.
Virus replication abides by single-step growth (or one-step growth). A typical single-step growth analysis includes four phases: initial phase, eclipse phase, synthetic phase, and latent phase. The initial phase is the moment of viral attachment to a receptor on cell membrane. The eclipse phase is the stage in which the uncoated virus is detected. The virus is noninfectious during this period, because it cannot connect with receptors on host cells. The synthetic phase is the period during which virions are assembled. The latent phase is also called the plateau stage, during which the virus particle is no longer increased. There are several methods of virus detection, including electron microscopy, infection assays, PCR, and enzymelinked immunosorbent assay. Nowadays, the PCR assay is a popular method of detecting viruses, especially real-time PCR. Lute et al, 10 Shi et al, 11 and Wit et al 12 used the Taqman prober to detect XMulV particles in CHO cells for the purpose of evaluating viral clearance; the limit of detection in their experiments ranged from 1.0 to 1.5 viral RNA copies/mL.
In this study, the SYBR Green fluorescence qPCR was used to detect virions, and the quantity of virions on different days was calculated using the 2
ÀDDCt method. The development of XMulV particles cocultured with CHO cells is a typical singlestep growth observed in the relative quantityetime plot. The amount of virions in CHO cells began to increase on Day 5 and showed an exponential growth frequency from Day 6 to Day 7.
Early studies have demonstrated that reverse transcriptase is contained in CHO cells. 1 Lie and his team 13 separated full-length gamma proviruses in CHO cells. The Env region had been sequenced in proviruses and the amplified complete env gene via PCR. However, Anderson et al, 14 using electron microscopy, have shown that there were deficient viruses in CHO cells. In our study, the gag gene was selected as the target gene. The reason for this choice was that there are three opening reading frames in retroviral genome: gag, pol, and env. gag, short for group-specific antigen, codes for core and structural proteins of the virus. Moreover, gag and pol make up the gagepol gene community to code for reverse transcriptase. Therefore, the gag gene is seen as the sign of retroviruses. 15, 16 The PG-4 SþLÀ assay was used to detect the activity of XMulV produced on CHO cells. Intrinsically, there are murine sarcoma viruses (MSVs) in PG-4 cells. When infected with murine leukemia viruses (MLVs), the PG-4 cells develop and produce pathological changes. Such dual infection by MSV and MLV of PG-4 cells causes a detectable cytopathic effect to estimate the infectivity of MLV. 17, 18 In our SþLÀ assay, the titer of XMulV produced on CHO cells on Day 7 was 8.78 AE 0.25 log 10 PFU/mL. The titer of the viral stock is more than 7 log 10 , which satisfies the basic requirement as recommended in biological products guidelines.
M. dunni cells and mink lung cells are always used as the host organisms for the propagation of XMulV, which are used in the evaluation of viral clearance at a laboratory scale in CHO-derived pharmaceutical proteins. Here, the CHO cell line is presented as a host cell for XMulV particles. The CHO cell line is used much more frequently in studies and is more familiar to laboratory researchers than M. dunni cells or mink lung cells. The cell line is easy to obtain, so it is convenient for researchers to passage XMulV particles and perform related studies. Furthermore, XMulV propagated on CHO cells (which was used for the evaluation of viral clearance in a validation study) and was closer to the endogenous virus contained in CHO cells. In addition, the study on the growth curve of XMulV on CHO cells is helpful not only for the collection of the virus, but also for virus transfection studies.
In conclusion, the CHO cell served as a host cell for XMulV particles and viral suspension harvested from CHO cells on Day 7, and can be used for the evaluation of viral clearance at a laboratory scale in pharmaceutical proteins derived from CHO cells.
